Diastika Biotekindo Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp131 (market cap 518.28B, 1.3M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume). The key difference: Diastika Biotekindo Tbk. is far larger — about 4.1× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 1.3M). Which is the better fit depends on your goals.
| CHEK | MEDS | |
|---|---|---|
Market Cap | 518.28B | 126.56B |
Volume | 1.3M | 319.74M |
Lot | 12.97K | 3.2M |
Turnover | 167.76M | 27.4B |
Average Price | 129.31 | 85.68 |
Value | 167.76M | 27.4B |
Indicative Equilibrium Price | 131 | 82 |
Indicative Equilibrium Volume | 47 | 12.79K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →